These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7906428)

  • 1. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
    Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
    Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
    [No Abstract]   [Full Text] [Related]  

  • 4. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis.
    Ciconelli RM; Ferraz MB; Visioni RA; Oliveira LM; Atra E
    Br J Rheumatol; 1996 Feb; 35(2):150-4. PubMed ID: 8612028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial.
    Capell HA; Madhok R; Hunter JA; Porter D; Morrison E; Larkin J; Thomson EA; Hampson R; Poon FW
    Ann Rheum Dis; 2004 Jul; 63(7):797-803. PubMed ID: 15194574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
    Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB
    Br J Rheumatol; 1997 Oct; 36(10):1082-8. PubMed ID: 9374925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study.
    Peltomaa R; Paimela L; Helve T; Leirisalo-Repo M
    Scand J Rheumatol; 1995; 24(6):330-5. PubMed ID: 8610215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.
    Faarvang KL; Egsmose C; Kryger P; Pødenphant J; Ingeman-Nielsen M; Hansen TM
    Ann Rheum Dis; 1993 Oct; 52(10):711-5. PubMed ID: 7903034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components.
    Dougados M; Combe B; Cantagrel A; Goupille P; Olive P; Schattenkirchner M; Meusser S; Paimela L; Rau R; Zeidler H; Leirisalo-Repo M; Peldan K
    Ann Rheum Dis; 1999 Apr; 58(4):220-5. PubMed ID: 10364900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis.
    Radia M; Furst DE
    J Rheumatol; 1988 Feb; 15(2):242-6. PubMed ID: 3283356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.
    Danis VA; Franic GM; Rathjen DA; Laurent RM; Brooks PM
    Ann Rheum Dis; 1992 Aug; 51(8):946-50. PubMed ID: 1358037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.
    Choy EH; Kingsley GH; Khoshaba B; Pipitone N; Scott DL;
    Ann Rheum Dis; 2005 Sep; 64(9):1288-93. PubMed ID: 15760929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.